Identification of Steroid Hormone-Regulated Genes in Breast Cancer

  • Bruce R. Westley
  • Felicity E. B. May
Part of the Methods in Molecular Medicine book series (MIMM, volume 120)

Summary

The measurement of the expression of hormonally regulated genes in breast cancer may provide an indication of its hormone responsiveness. In addition, these genes may provide novel therapeutic targets. This chapter reviews the hormonally responsive genes that have been identified in breast cancer cell lines and tumors, using differential hybridization, differential display, serial analysis of gene expression, and array technology. The biological relevance of the genes identified is discussed.

Key Words

Estrogen breast cancer gene expression SAGE regulation of gene expression microarray 

References

  1. 1.
    Beatson, G. T. (1896) On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases. Lancet 2, 104–107.CrossRefGoogle Scholar
  2. 2.
    Toft, D. and Gorski, J. (1966) A receptor molecule for estrogens: isolation from the rat uterus and preliminary characterization. Proc. Natl. Acad. Sci. USA 55, 1574–1581.PubMedCrossRefGoogle Scholar
  3. 3.
    Osborne, C. K., Yochmowitz, M. G., Knight, W. A. D., and McGuire, W. L. (1980) The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46, 2884–2888.PubMedCrossRefGoogle Scholar
  4. 4.
    Jensen, E. V. and Jacobsen, H. I. (1960) Fate of steroidal estrogens in target tissues, in Biological Activities of Steroids in Relation to Cancer (Pincus, G., Vollmer, E. P., eds.). Academic, New York, NY, pp. 161–174.Google Scholar
  5. 5.
    Greene, G. L., Closs, L. E., Fleming, H., De Sombre, E. R., and Jensen, E. V. (1977) Antibodies to estrogen receptor: immunochemical similarity of estrophilin from various mammalian species. Proc. Natl. Acad. Sci. USA 74, 3681–3685.PubMedCrossRefGoogle Scholar
  6. 6.
    Green, S., Walter, P., Kumar. V., et al. (1986) Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320, 134–139.PubMedCrossRefGoogle Scholar
  7. 7.
    Clayton, S. J., May, F. E. B., and Westley, B. R. (1997) Insulin-like growth factors control the regulation of oestrogen and progesterone receptor expression by oestrogens. Mol. Cell. Endocrinol. 128, 57–68.PubMedCrossRefGoogle Scholar
  8. 8.
    Westley, B. R. and May, F. E. B. (1988) Oestrogen regulates oestrogen receptor mRNA levels in an oestrogen-responsive human breast cancer cell line. Biochem. Biophys. Res. Commun. 155, 1113–1118.PubMedCrossRefGoogle Scholar
  9. 9.
    Donaghue, C., Westley, B. R., and May, F. E. B. (1999) Selective promoter usage of the human estrogen receptor-alpha gene and its regulation by estrogen. Mol. Endocrinol. 13, 1934–1950.PubMedCrossRefGoogle Scholar
  10. 10.
    McGuire, W. L. and Horwitz, K. B. (1978) Progesterone receptors in breast cancer, in Hormones, Receptors and Breast Cancer (McGuire, W. L., ed.). Raven, New York, NY, pp. 31–42.Google Scholar
  11. 11.
    May, F. E. B., Johnson, M. D., Wiseman, L. R., Wakeling, A. E., Kastner, P., and Westley, B. R. (1989) Regulation of progesterone receptor mRNA by estradiol and antioestrogens in breast cancer cell lines. J. Steroid Biochem. 33, 1035–1041.PubMedCrossRefGoogle Scholar
  12. 12.
    Elledge, R. M., Green, S., Pugh, R., et al. (2000) Estrogen receptor (ER) and progesterone receptor (PgR) by ligand-binding assay compared with ER, PgR and pS2 by immunohistochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study. Int. J. Cancer 89, 111–117.PubMedCrossRefGoogle Scholar
  13. 13.
    Stewart, A. J., Johnson, M. D., May, F. E. B., and Westley, B. R. (1990) Role of type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J. Biol. Chem. 265, 21,172–178.PubMedGoogle Scholar
  14. 14.
    Molloy, C. A., May, F. E. B., and Westley, B. R. (2000) Insulin receptor substrate-1 expression is regulated by estrogen in the MCF-7 human breast cancer cell line. J. Biol. Chem. 275, 12,565–12,571.PubMedCrossRefGoogle Scholar
  15. 15.
    Edwards, D. P, Adams, D. J., and McGuire, W. L. (1981) Estradiol stimulates synthesis of a major intracellular protein in a human breast cancer cell line (MCF-7). Breast Cancer Res. Treat. 1, 209–223.PubMedCrossRefGoogle Scholar
  16. 16.
    Faucher, C., Capdevielle, J., Canal, I., et al. (1993) The 28-kDa protein whose phosphorylation is induced by protein kinase C activators in MCF-7 cells belongs to the family of low molecular mass heat shock proteins and is the estrogen-regulated 24-kDa protein. J. Biol. Chem. 268, 15,168–15,173.PubMedGoogle Scholar
  17. 17.
    Westley, B. R. and Rochefort, H. (1980) A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell 20, 353–362.PubMedCrossRefGoogle Scholar
  18. 18.
    Westley, B. and May, F. E. B. (1987) Oestrogen regulates cathepsin D mRNA levels in oestrogen responsive human breast cancer cells. Nucleic Acids Res. 15, 3773–3786.PubMedCrossRefGoogle Scholar
  19. 19.
    Chalbos, D. and Rochefort, H. (1984) A 250-kilodalton cellular protein is induced by progestins in two human breast cancer cell lines MCF-7 and T47D. Biochem. Biophys. Res. Commun. 121, 421–427.PubMedCrossRefGoogle Scholar
  20. 20.
    Chalbos, D., Chambon, M., Ailhaud, G., and Rochefort, H. (1987) Fatty acid synthase and its mRNA are induced by progestins in breast cancer cells. J. Biol. Chem. 262, 9923–9926.PubMedGoogle Scholar
  21. 21.
    O’Farrell, P. H. (1975) High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 250, 4007–4021.Google Scholar
  22. 22.
    Masiakowski, P., Breathnach, R., Bloch, J., Gannon, F., Krust, A., and Chambon, P. (1982) Cloning of cDNA sequences of hormone-regulated genes from MCF-7 human breast cancer cell line. Nucleic Acids Res. 10, 7895–7903.PubMedCrossRefGoogle Scholar
  23. 23.
    Prud’homme, J. F., Fridlansky, F., Le Cunff, M., et al. (1985) Cloning of a gene expressed in human breast cancer and regulated by estrogen in MCF-7 cells. DNA 4, 11–21.CrossRefGoogle Scholar
  24. 24.
    May, F. E. B. and Westley, B. R. (1986) Cloning of estrogen-regulated messenger RNA sequences from human breast cancer cells. Cancer Res. 46, 6034–6040.PubMedGoogle Scholar
  25. 25.
    May, F. E. B. and Westley, B. R, (1988) Identification and characterization of estrogen-regulated RNAs in human breast cancer cells. J. Biol. Chem. 263, 12,901–12,908.PubMedGoogle Scholar
  26. 26.
    May, F. E. B. and Westley, B. R. (1987) Effects of tamoxifen and 4-hydroxytamoxifen on the pNR-1 and pNR-2 estrogen-regulated RNAs in human breast cancer cells. J. Biol. Chem. 262, 15,894–15,899.PubMedGoogle Scholar
  27. 27.
    Manning, D. L., Daly, R., Lord, P. G., Kelly, K. F., and Green, C. D. (1988) Effects of oestrogen on the expression of a 4.4 kb mRNA in the ZR-75-1 human breast cancer cell line. Mol. Cell. Endocrinol. 59, 205–212.PubMedCrossRefGoogle Scholar
  28. 28.
    Manning, D. L., Archibald, L. H., and Ow, K. T. (1990) Cloning of estrogenresponsive messenger RNAs in the T-47D human breast cancer cell line. Cancer Res. 50, 4098–4104.PubMedGoogle Scholar
  29. 29.
    Manning, D. L. and Nicholson, R. I. (1993) Isolation of pMGT1: a gene that is repressed by oestrogen and increased by antioestrogens and antiprogestins. Eur. J. Cancer 29A, 759–762.PubMedCrossRefGoogle Scholar
  30. 30.
    Prest, S. J., May F. E. B., and Westley B. R. (2002) The estrogen-regulated protein, TFF1, stimulates migration of human breast cancer cells. FASEB J. 16, 592–994.PubMedGoogle Scholar
  31. 31.
    May, F. E. B., Church, S. T., Major, S., and Westley, B. R. (2003) The closely related estrogen-regulated trefoil proteins TFF1 and TFF3 have markedly different hydrodynamic properties, overall charge and distribution of surface charge. Biochemistry 42, 8250–8259.PubMedCrossRefGoogle Scholar
  32. 32.
    Taylor, K. M. and Nicholson, R. I. (2003) The LZT proteins: the LIV-1 subfamily of zinc transporters. Biochim. Biophys. Acta 1611, 16–30.PubMedCrossRefGoogle Scholar
  33. 33.
    Glondu, M., Liauet-Coopman, E., Derocq, D., Platet, N., Rochefort, H., and Garcia, M. (2002) Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumour growth and experimental lung metastasis of human breast cancer cells. Oncogene 21, 5127–5134.PubMedCrossRefGoogle Scholar
  34. 34.
    Kuang, W. W., Thompson, D. A., Hoch, R. V., and Weigel, R. J. (1998) Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line. Nucleic Acids Res. 26, 1116–1123.PubMedCrossRefGoogle Scholar
  35. 35.
    Ghosh, M. G., Thompson, D. A., and Weigel, R. J. (2000) PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. Cancer Res. 60, 6367–6375.PubMedGoogle Scholar
  36. 36.
    Liang, P. and Pardee, A. B. (1992) Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257, 967–971.PubMedCrossRefGoogle Scholar
  37. 37.
    Ediger, T. R., Kraus, W. L., Weinman, E. J., and Katzenellenbogen, B. S. (1999) Estrogen receptor regulation of the Na+/H+ exchange regulatory factor. Endocrinology 140, 2976–2982.PubMedCrossRefGoogle Scholar
  38. 38.
    Stephen, R., Corcoran, D., and Darbre, P. D. (1998) A novel oestrogen-regulated gene in human breast cancer cells identified by differential display. J. Mol. Endocrinol. 20, 375–380.PubMedCrossRefGoogle Scholar
  39. 39.
    Thompson, D. A. and Weigel, R. J. (1998) Characterization of a gene that is inversely correlated with estrogen receptor expression (ICERE-1) in breast carcinomas. Eur. J. Biochem. 252, 169–177.PubMedCrossRefGoogle Scholar
  40. 40.
    Lapointe, J. and Labrie, C. (1999) Identification and cloning of a novel androgenresponsive gene, uridine diphosphoglucose dehydrogenase, in human breast cancer cells. Endocrinology 140, 4486–4493.PubMedCrossRefGoogle Scholar
  41. 41.
    Hamilton, J. A., Callaghan, M. J., Sutherland, R. L., and Watts, C. K. (1997) Identification of PRG1, a novel progestin-responsive gene with sequence homology to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Mol. Endocrinol. 11, 490–502.PubMedCrossRefGoogle Scholar
  42. 42.
    Miller, M. M., James, R. A., Richer, J. K., Gordon, D. F., Wood, W. M., and Horwitz, K. B. (1997) Progesterone regulated expression of flavin-containingcontaining monooxygenase 5 by the B-isoform of progesterone receptors: implications for tamoxifen carcinogenicity. J. Clin. Endocrinol. Metab. 82, 2956–2961.PubMedCrossRefGoogle Scholar
  43. 43.
    Purmonen, S., Ahola, T. M., Pennanen, P., et al. (2002) HDLG5/KIAA0583, encoding a MAGUK-family protein, is a primary progesterone target gene in breast cancer cells. Int. J. Cancer, 102, 1–6.PubMedCrossRefGoogle Scholar
  44. 44.
    Ahola, T. M., Purmonen, S., Pennanen, P., Zhuang, Y. H., Tuohimaa, P., and Ylikomi, T. (2002) Progestin upregulates G-protein-coupled receptor 30 in breast cancer cells. Eur. J. Biochem. 269, 2485–2490.PubMedCrossRefGoogle Scholar
  45. 45.
    Kester, H. A., van der Leede, B. M., van der Saag, P. T., and van der Burg, B. (1997) Novel progesterone target genes identified by an improved differential display technique suggest that progestin-induced growth inhibition of breast cancer cells coincides with enhancement of differentiation. J. Biol. Chem. 272, 16,637–16,643.PubMedCrossRefGoogle Scholar
  46. 46.
    Inadera, H., Hashimoto, S., Dong, H. Y., et al. (2000) WISP2 as a novel estrogenresponsive gene in human breast cancer cells. Biochem. Biophys. Res. Commun. 275, 108–114.PubMedCrossRefGoogle Scholar
  47. 47.
    Charpentier, A. H., Bednarek, A. K., Daniel, R. L., et al. (2000) Effects of estrogen on global gene expression: identification of novel targets of estrogen action. Cancer Res. 60, 5977–5983.PubMedGoogle Scholar
  48. 48.
    Seth, P., Krop, I., Porter, D., and Polyak, K. (2002) Novel estrogen and tamoxifen induced genes identified by SAGE (Serial Analysis of Gene Expression) Oncogene 21, 836–843.PubMedCrossRefGoogle Scholar
  49. 49.
    Perez-Enciso, M. and Tenenhaus, M. (2003) Prediction of clinical outcome with microarray data: a partial least squares discriminant analysis (PLS-DA) approach. Hum Genet. 112, 581–592.PubMedGoogle Scholar
  50. 50.
    Sorlie, T., Perou, C. M., Tibshirani, R., et al. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA 98, 10,869–10,874.PubMedCrossRefGoogle Scholar
  51. 51.
    van de Vijver, M. J., He, Y.D., van’t Veer, L. J., et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347, 1999–2009.PubMedCrossRefGoogle Scholar
  52. 52.
    Soulez, M. and Parker, M. G. (2001) Identification of novel oestrogen receptor target genes in human ZR-75-1 breast cancer cells by expression profiling. J. Mol. Endocrinol. 27, 259–274.PubMedCrossRefGoogle Scholar
  53. 53.
    Bouras, T., Southey, M. C., Chang, A. C., et al. (2002) Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer. Cancer Res. 621, 289–295.Google Scholar
  54. 54.
    Hoch, R.V., Thompson, D. A., Baker, R. J., and Weigel, R. J. (1999) GATA-3 is expressed in association with estrogen receptor in breast cancer. Int. J. Cancer. 84, 122–128.PubMedCrossRefGoogle Scholar
  55. 55.
    Finlin, B. S., Gau, C. L., Murphy, G. A., et al. (2001) RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer. J. Biol. Chem. 276, 42,259–42,267.PubMedCrossRefGoogle Scholar
  56. 56.
    Inoue, A., Yoshida, N., Omoto, Y., et al. (2002) Development of cDNA microarray for expression profiling of estrogen-responsive genes. J. Mol. Endocrinol. 29, 175–192.PubMedCrossRefGoogle Scholar
  57. 57.
    Bertucci, F., Houlgatte, R., Benziane, A., et al. (2000) Gene expression profiling of primary breast carcinomas using arrays of candidate genes. Hum. Mol. Genet. 9, 2981–2991.PubMedCrossRefGoogle Scholar
  58. 58.
    Perou, C. M., Sorlie, T., Elsen, M. B., et al. (2000) Molecular portraits of human breast tumours. Nature 406, 747–752.PubMedCrossRefGoogle Scholar
  59. 59.
    Gruvberger, S., Ringner, M., Chen, Y., et al. (2001) Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res. 61, 5979–5984.PubMedGoogle Scholar
  60. 60.
    West, M., Blanchette, C., Dressman, C., et al. (2001) Predicting the clinical status of human breast cancer by using gene expression profiles. Proc. Natl. Acad. Sci. USA 98, 11,462–11,467.PubMedCrossRefGoogle Scholar
  61. 61.
    Bertucci, F., Nasser, V., Granjeaud, S., et al. (2002) Gene expression profiles of poor-prognosis primary breast cancer correlate with survival. Hum. Mol. Genet. 11, 863–872.PubMedCrossRefGoogle Scholar
  62. 62.
    van’t Veer, L. J., Dai, H., van de Vijver, M. J., et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530–536.CrossRefGoogle Scholar
  63. 63.
    Ciocca, D. R., Oesterreich, S., Chamness, G. C., McGuire, W. L., and Fuqua, S. A. (1993) Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review. J. Natl. Cancer Inst. 85, 1558–1570.PubMedCrossRefGoogle Scholar
  64. 64.
    Oesterreich, S., Hilsenbeck, S. G., Ciocca, D. R., et al. (1996) The small heat shock protein HSP27 is not an independent prognostic marker in axillary lymph node-negative breast cancer patients. Clin. Cancer Res. 2, 1199–1206.PubMedGoogle Scholar
  65. 65.
    May, F. E. B., Smith, D. J., and Westley, B. R. (1993) The human cathepsin Dencoding gene is transcribed from an estrogen-regulated and a constitutive start point. Gene 134, 277–282.PubMedCrossRefGoogle Scholar
  66. 66.
    Westley, B. R. and May, F. E. B. (1996) Cathepsin D and breast cancer. Eur. J. Cancer 32, 15–24.CrossRefGoogle Scholar
  67. 67.
    Ribieras, S., Tomasetto, C., and Rio, M. C. (1998) The pS2/TFF1 trefoil factor, from basic research to clinical applications. Biochim. Biophys. Acta 1378, F61–F77.PubMedGoogle Scholar
  68. 68.
    Henry, J. A., Piggott, N. H., Mallick U. K., et al. (1991) pNR-2/pS2 immunohistochemical staining in breast cancer correlation with prognostic factors and endocrine response. Br. J. Cancer 63, 615–622.PubMedCrossRefGoogle Scholar
  69. 69.
    May, F. E. B. and Westley, B. R. (1997) Expression of human intestinal trefoil factor in malignant cells and its regulation by oestrogen in breast cancer cells. J. Pathol. 182, 404–413.PubMedCrossRefGoogle Scholar
  70. 70.
    Manning, D. L., Robertson, J. F., Ellis, I. O., et al. (1994) Oestrogen-regulated genes in breast cancer: association of pLIV1 with lymph node involvement. Eur. J. Cancer 30, 675–678.CrossRefGoogle Scholar
  71. 71.
    Parry, P., Wei, Y., and Evans, G. (1994) Cloning and characterization of the t(X;11) breakpoint from a leukemic cell line identify a new member of the fork head gene family. Genes Chromosomes Cancer 11, 79–84.PubMedCrossRefGoogle Scholar
  72. 72.
    Galili, N., Davis, R. J., Fredericks, W. J., et al. (1993) Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat. Genet. 5, 230–235.PubMedCrossRefGoogle Scholar
  73. 73.
    Lin, L., Miller, C. T., Contreras, J. I., et al. (2002) The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas. Cancer Res. 62, 5273–5279.PubMedGoogle Scholar
  74. 74.
    Crowe, A. J., Sang, L., Li, K. K., Lee, K. C., Spear, B. T., and Barton, M. C. (1999) Hepatocyte nuclear factor 3 relieves chromatin-mediated repression of the alpha-fetoprotein gene. J. Biol. Chem. 274, 25,113–25,120.PubMedCrossRefGoogle Scholar
  75. 75.
    Patient, R. K. and McGhee, J. D. (2002) The GATA family (vertebrates and invertebrates). Curr. Opin. Genet. Dev. 12, 416–422.PubMedCrossRefGoogle Scholar
  76. 76.
    Lowry, J. A. and Atchley, W. R. (2000) Molecular evolution of the GATA family of transcription factors: conservation within the DNA-binding domain. J. Mol. Evol. 50, 103–115.PubMedGoogle Scholar
  77. 77.
    Masaki, T., Noguchi, H., Kobayashi, M., Yoshida, M., and Takamatsu, K. (2000) Isolation and characterisation of the gene encoding mouse tax-responsive element-binding protein (TREB) 5. DNA Res. 7, 187–193.PubMedCrossRefGoogle Scholar
  78. 78.
    Reimold, A. M., Ponath, P. D., Li, Y. S., et al. (1996) Transcription factor B cell lineage-specific activator protein regulates the gene for human X-box binding protein 1. J. Exp. Med. 183, 393–401.PubMedCrossRefGoogle Scholar
  79. 79.
    Takahashi, S., Suzuki, S., Inaguma, S., et al. (2002) Down-regulation of human X-box binding protein 1 (hXBP-1) expression correlates with tumor progression in human prostate cancers. Prostate 50, 154–161.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 2006

Authors and Affiliations

  • Bruce R. Westley
    • 1
  • Felicity E. B. May
    • 2
  1. 1.Northern Institute for Cancer Research, Medical SchoolThe University of Newcastle upon TyneNewcastle upon TyneUK
  2. 2.Northern Institute for Cancer Research, Medical School, Framlington PlaceThe University of Newcastle upon TyneNewcastle upon TyneUK

Personalised recommendations